Nan Fung Group Holdings Ltd
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1782539
KAI TAK, K3
Position in RXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,184,703
+$357,172 QoQ
Shares Held
595,287
0.0% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
1.67%
of 13F equity value
Holder Rank
#51
of 344 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nan Fung Group Holdings Ltd holds $127,740,239 across 20 Biotechnology names. RXRX ranks #16 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MPLT |
MapLight Therapeutics, Inc.
|
971,253 | $34,809,707 | |
| 2 | LBRX |
Lb Pharmaceuticals Inc
|
630,657 | $20,467,972 | |
| 3 | EVMN |
Evommune, Inc.
|
1,441,032 | $19,151,315 | |
| 4 | HELP |
Cybin Inc.
|
987,222 | $6,525,537 | |
| 5 | INCY |
Incyte Corp
|
53,742 | $6,092,193 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
49,120 | $5,453,793 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
15,722 | $4,480,298 | |
| 8 | OCS |
Oculis Holding AG
|
300,565 | $4,168,836 |
All Filings in RXRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,184,703 | 595,287 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,827,531 | 595,287 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,434,723 | 595,287 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,905,000 | 595,287 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,362,926 | 664,610 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,515,786 | 664,610 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,492,763 | 664,610 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||